The intellectual property facilitates modulation of cannabinoid production.Read More
Tags :22nd Century Group
The cigarettes will be used to validate the benefits minimally addictive levels of nicotine.Read More
The proposed rule was removed from the agenda late last year without significant explanation. Read More
The allowed claims cover methods of manipulating plant metabolism and alkaloid levels.Read More
Having a modified exposure claim would greatly boost 22nd Century’s sales, says CEO. Read More
Koganov is an expert in the development of natural products using biotechnology.Read More
The company's manufacturing facility has remained open and has been able to fulfill orders without any backlog. Read More
22nd Century Group and North Carolina State University have developed several new very-low-nicotine tobacco varieties that contain no foreign DNA and no trace of genetic modification.Read More
22nd Century Group, a plant biotechnology company and leader in tobacco harm reduction, has announced that it will open specialized laboratories in western New York, USA, dedicated to new scientific research at substantially lower costs Read More
Joseph Pandolfino has stepped down as chairman and CEO of 22nd Century Group. He will remain a member of the company’s board of directors. According to 22nd Century Group, Pandolfino’s entrepreneurial spirit and Read More
